Erika Kiniry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Systematic Testing for Influenza and Coronavirus Disease 2019 Among Patients With Respiratory Illness”.

Systematic Testing for Influenza and Coronavirus Disease 2019 Among Patients With Respiratory Illness

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1023

N/A

0DataRank · unranked

5 citations

Jennifer K. Meece, John V. Williams, Emily T. Martin, Manjusha Gaglani, Michael L. Jackson +23 more

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants

Science(2021)10.1126/science.abj4176

N/A

0DataRank · unranked

602 citations

Sarah O’Connell, Stephen D. Schmidt, Sijy O’Dell, Chloe Adrienna Talana, Lilin Lai +82 more

Effectiveness of two and three mRNA COVID‐19 vaccine doses against Omicron‐ and Delta‐Related outpatient illness among adults, October 2021–February 2022

Influenza and Other Respiratory Viruses(2022)10.1111/irv.13029

N/A

0DataRank · unranked

24 citations

Jessie R. Chung, H. Keipp Talbot, Carlos G. Grijalva, Karen J. Wernli, Erika Kiniry +16 more

Burden of medically attended influenza infection and cases averted by vaccination – United States, 2016/17 through 2018/19 influenza seasons

Vaccine(2022)10.1016/j.vaccine.2022.11.011

N/A

0DataRank · unranked

7 citations

C. Hallie Phillips, Stacie Wellwood, Erika Kiniry, Lisa A. Jackson, Emily T. Martin +10 more

Effectiveness of 2 and 3 mRNA COVID-19 Vaccines Doses against Omicron and Delta-Related Outpatient Illness among Adults, October 2021 – February 2022

medRxiv(2022)10.1101/2022.04.06.22273535

N/A

0DataRank · unranked

1 citations

Jessie R. Chung, H. Keipp Talbot, Carlos G. Grijalva, Karen J. Wernli, Erika Kiniry +16 more

Late‐Season Influenza Vaccine Effectiveness Against Medically Attended Outpatient Illness, United States, December 2022–April 2023

Influenza and Other Respiratory Viruses(2024)10.1111/irv.13342

N/A

0DataRank · unranked

12 citations

Philip Shirk, Manjusha Gaglani, Manohar B. Mutnal, Mary Patricia Nowalk, Krissy Moehling Geffel +19 more

Reduced Effectiveness of Repeat Influenza Vaccination: Distinguishing Among Within-Season Waning, Recent Clinical Infection, and Subclinical Infection

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae220

N/A

0DataRank · unranked

8 citations

Barbra A. Dickerman, Huong Q. Nguyen, Emily T. Martin, Manjusha Gaglani, Karen J. Wernli +22 more

Elevated body mass index is not significantly associated with reduced influenza vaccine effectiveness

Scientific Reports(2024)10.1038/s41598-024-72081-z

N/A

0DataRank · unranked

5 citations

Huong Q. Nguyen, Erika Kiniry, C. Hallie Phillips, Manjusha Gaglani, Emily T. Martin +6 more

Absolute and Relative Effectiveness of Cell Culture–Based and Egg–Based Quadrivalent Inactivated Influenza (Flu) Vaccine Products From the 2014–2015 to 2018–2019 Seasons, US Flu VE Network

Clinical Infectious Diseases(2025)10.1093/cid/ciaf579

N/A

0DataRank · unranked

0 citations

Chandni Raiyani, Kempapura Murthy, Michael Smith, Briget da Graca, Gueorgui Dubrocq +13 more